RefMet Compound Details
RefMet ID, RefMet name, exact mass and formula | ||
RefMet ID | RM0153766 | |
---|---|---|
RefMet name | 15-Keto-PGE2 | |
Systematic name | 9,15-dioxo-11R-hydroxy-5Z,13E-prostadienoic acid | |
Synonyms | PubChem Synonyms | |
Sum Composition | FA 20:5;O3 | View other entries in RefMet with this sum composition |
Exact mass | 350.209325 (neutral) | Calculate m/z:
View other RefMet entries with this exact (neutral) mass: +/- 0.05 amu +/- 0.1 amu +/- 0.2 amu +/- 0.5 amu |
Formula | C20H30O5 | View other entries in RefMet with this formula |
Molecular descriptors | ||
Molfile | 2396 (Download molfile/View MW Metabolite Database details) | |
InChI | InChI=1S/C20H30O5/c1-2-3-6-9-15(21)12-13-17-16(18(22)14-19(17)23)10-7-4-5-8-11-20(24)25/h4,7,12-13,16-17,19,23H,2-3,5-6,8-11,14H2, 1H3,(H,24,25)/b7-4-,13-12+/t16-,17-,19-/m1/s1 | |
InChIKey | YRTJDWROBKPZNV-KMXMBPPJSA-N | View other enantiomers/diastereomers of this metabolite in RefMet |
SMILES | CCCCCC(=O)/C=C/[C@@H]1[C@@H](C/C=C\CCCC(=O)O)C(=O)C[C@H]1O
Run Tanimoto similarity search (with similarity coefficient >=0.6) | |
Chemical/Biochemical Classification | ||
Super Class | Fatty Acyls | |
Main Class | Eicosanoids | |
Sub Class | Prostaglandins | |
Distribution of 15-Keto-PGE2 in NMDR studies | ||
Species | Plot Species distribution | |
Sample source | Plot Sample source(tissue) distribution | |
Platform | Platform (MS/NMR) used for detection | |
Chromatography | Chromatography methods used for detection | |
Studies | NMDR Studies reporting 15-Keto-PGE2 | |
External Links | ||
Pubchem CID | 5280719 | |
LIPID MAPS | LMFA03010030 | |
ChEBI ID | 15547 | |
KEGG ID | C04707 | |
HMDB ID | HMDB0003175 | |
Chemspider ID | 4444303 | |
MetaCyc ID | HYDROXY-915-DIOXOPROSTA-13-ENOATE | |
Structural annotation level | ||
Annotation level | 1 (1:Known structure; 2:Known regiochemistry; 3:Partial structure; 4:Sum-composition) |
Table of KEGG reactions in human pathways involving 15-Keto-PGE2
Rxn ID | KEGG Reaction | Enzyme |
---|---|---|
R02580 | Prostaglandin E2 + NAD+ <=> (5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate + NADH + H+ | (5Z,13E)-(15S)-11alpha,15-Dihydroxy-9-oxoprost-13-enoate:NAD+15-oxidoreductase |
R04556 | (5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate + NAD+ <=> (5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate + NADH + H+ | (5Z)-(15S)-11alpha-hydroxy-9,15-dioxoprostanoate:NAD+ delta13-oxidoreductase |
R04557 | (5Z)-11alpha-Hydroxy-9,15-dioxoprostanoate + NADP+ <=> (5Z,13E)-11alpha-Hydroxy-9,15-dioxoprost-5,13-dienoate + NADPH + H+ | (5Z)-(15S)-11alpha-hydroxy-9,15-dioxoprostanoate:NADP+ delta13-oxidoreductase |
Table of KEGG human pathways containing 15-Keto-PGE2
Pathway ID | Human Pathway | # of reactions |
---|---|---|
hsa00590 | Arachidonic acid metabolism | 3 |